- Mikawaya recalls certain Mikawaya Brand Chocolate Chocolate Mochi Ice Cream that may contain undeclared peanuts
Los Angeles, California, 2017-May-12 — /EPR Retail News/ — Mikawaya is issuing a voluntary recall of a limited number of Mikawaya Brand Chocolate Chocolate Mochi Ice Cream, which may inadvertently contain peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of a serious or life-threatening allergic reaction if they consume the product. Only product labeled with UPC code of 070934990609 and lot number LOT 090-17 is included in this recall. The UPC code can be found on the back of the box and the lot number is printed on the top enclosure.
The affected product is sold in a paperboard box, containing 9.1oz (258g) of 6-1.5oz (43g) pieces with UPC code of 070934990609 and lot number LOT 090-17. The product was distributed to all Trader Joe’s stores nationwide and has been removed from sale.
The recall was initiated after receiving one customer report that a Chocolate Chocolate Mochi Ice Cream contained the presence of peanut butter. Mikawaya has not received any reports of illness or allergic reactions associated with this product.
No other Mikawaya Brand products besides this specific lot of Chocolate Chocolate Mochi Ice Cream are affected by this voluntary recall.
Customers who have purchased Mikawaya Chocolate Chocolate Mochi Ice Cream with the affected UPC code and lot number, and have an allergy or sensitivity to peanuts, are advised not to consume the product. Customers may return the product to any Trader Joe’s for a full refund. Customers with questions may contact Mikawaya at (323) 587-5504 (Monday – Friday) between the hours of 9:00 A.M. and 5:00 P.M. Pacific Time.
The company is placing a notification on the Food Allergy Research and Education (FARE) website, www.foodallergy.org.
For additional information, please visit www.mikawayamochi.com/voluntarylimitedrecall
Consumers Contact:
(323) 587-5504
Media Contact:
Kim Le / Carmen Hernandez
kle@konnectagency.com /
chernandez@konnectagency.com
Source: FDA
###